Major US investment bank ratings are used to track the latest valuations and target prices on Wall Street daily, and to explore potential stock investment opportunities.

Today's Key Ratings and Concerns
Wedbush: Maintained Astria Therapeutics ( Astria Therapeutics Inc Ordinary Shares(ATXS.US) ) rating at “Outperform,” raising the price target from $27 to $28.
HC Wainwright & Co.: Maintained a "Buy" rating on LifeMD ( LifeMD Inc Ordinary Shares(LFMD.US) ), raising the price target from $12 to $14.
Citizens Capital Markets: Maintained Zevra Therapeutics ( Zevra Therapeutics Inc Ordinary Shares(ZVRA.US) ) rating at “Outperform,” raising the price target from $17 to $18.
BMO Capital: Initial rating for Rocket Pharmaceuticals Rocket Pharmaceuticals, Inc.(RCKT.US) ) at "Outperform", with a $50 price target.
Piper Sandler: Maintained Inozyme Pharma(INZY.US) ) rating at "Overweight", lowered price target from $30 to $23.

comments:
Target price unit and current price: US dollar;
Current Price: As of the latest closing price of US stocks;
Potential increase/decrease ratio = (Agency target price - current price) / current price 100% (Current price = last closing price up to the time of census)

Lifting
B of A Securities: Upgraded ACV Auctions, Inc. Class A ( ACV Auctions, Inc. Class A(ACVA.US) ) to "Buy", lowered price target from $22 to $20.
Barclays: Maintained American Homes 4 Rent ( American Homes 4 Rent Class A(AMH.US) ) rating at "market-weight," raising the price target from $37 to $38.
Jefferies: Maintained a "Buy" rating on Arcutis Biotherapeutics ( Arcutis Biotherapeutics(ARQT.US) ), raising the price target from $16 to $19.
HC Wainwright & Co.: Maintained a "Buy" rating on Avino Silver Avino Silver & Gold Mines Ltd.(ASM.US) ), raising the price target from $1.9 to $2.2.
JP Morgan: Raised Autohome ( Autohome, Inc. Sponsored ADR Class A(ATHM.US) ) to "Overweight", with a price target increase from $24 to $36.

First coverage
Piper Sandler: has given Atlas Energy Solutions Inc.(AESI.US) an initial rating of "Overweight", with a price target of $22.
JP Morgan: Initial rating for ANI Pharmaceuticals, Inc.(ANIP.US) ) with an "Overweight" recommendation and a price target of $85.
Citizens Capital Markets: Initial rating for Cidara Therapeutics, Inc.(CDTX.US) ) at "Outperform", with a $46 price target.
UBS: Initial rating for DT Midstream ( DT Midstream, Inc. Common Stock(DTM.US) ) is "Buy", with a target price of $102.

reduction
Barclays: Maintained a "market-weight" rating on American American Airlines Group, Inc.(AAL.US) ), while lowering the price target from $18 to $16.
B of A Securities: Maintained a "Neutral" rating on American American Airlines Group, Inc.(AAL.US) ), lowering the price target from $20 to $16.
Morgan Stanley: Maintained an “Overweight” rating on Apple Apple Inc.(AAPL.US) ), lowering the price target from $275 to $252.
Baird: Maintains a "Neutral" rating on Agenus Inc.(AGEN.US) ), lowers the price target from $6 to $3.
Citigroup: Maintained a "Neutral" rating on ArcBest ArcBest Corporation(ARCB.US) ), lowering the price target to $83 from $103.
B of A Securities: Maintained ArcBest ( ArcBest Corporation(ARCB.US) ) rating at “Underperform,” lowered the price target from $100 to $73.

Editor's Note: This content was generated by Sahm's AI-powered SaaS tool and reviewed by our editorial team.
Hazard Warning:
Investing involves risks, and securities prices may rise, fall, or even become worthless. Investing does not guarantee profits and may result in losses. Past performance does not necessarily reflect future performance. Before making any investment decision, investors should evaluate their financial situation, investment objectives, experience, and risk tolerance, and understand the nature of the investment products and the risks associated with them. For further details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, you are advised to seek independent professional advice.